Lilly.com is the official website of Eli Lilly and Company, a pharmaceutical company that specializes in developing medicines that improve the quality of life for people all over the world. The website provides information on the company's products, services, and research initiatives. It serves as a resource for healthcare professionals, patients, and investors with its comprehensive information on drug treatments, clinical trials, and disease management. Visitors to lilly.com can also access educational and scientific resources on diabetes, cancer, and other health-related topics. The site is user-friendly, well-structured, and offers a variety of services, including news and media updates, career opportunities, and contact information for the company.
Clowes' negotiations with researchers who developed insulin at the University of Toronto helped launched the first successful large-scale production of insulin in 1923.en.wikipedia.orgThe success of insulin enabled the company to attract well-respected scientists and, with them, make more medical advances.
The success of insulin enabled the company to attract well-respected scientists and, with them, make more medical advances.en.wikipedia.orgEli Lilly enjoyed effective monopoly on the sale of insulin in the U.S. for almost two years, until the first of the new American licensees, Frederick Stearns & Co., entered the market in June 1924.
Lilly tested three different doses of Mounjaro in five clinical trials, either as a monotherapy or as an addition to other diabetes medicines. The Lilly drug also beat the two long-acting insulins.medcitynews.comIndianapolis-based Eli Lilly already markets a GLP-1 agonist, the blockbuster drug Trulicity. Mounjaro combines that mechanism with GIP activation in a single molecule.
-
EncryptedSite is Encrypted
-
CountryHosted in United States
-
CityParis, Paris
-
Latitude\Longitude48.8607 / 2.3281 Google Map
-
Traffic rank#7,019 Site Rank
-
Site age33 yrs old
-
Site Owner informationWhois info
-
Stock priceLLY,LLY,LLY,(NYSE),361.67 USD,361.67 USD,361.67 USD,,+0.9 (0.25%)
-
Traded asNYSE,:,LLY,S&P 100,component,S&P 500,component
-
Founded1876
-
FounderEli Lilly
-
HeadquartersIndianapolis, Indiana,, U.S.
-
Key peopleDavid A. Ricks (,Chair,,,President,, &,CEO,),Anat Ashkenazi (,CFO,)
-
OwnerLilly Endowment,(11.3%)
-
Number of employeesc. 35,000 (2021)
#7,019
33 yrs
United States